Candel Therapeutics, Inc. - Common Stock (CADL)

Candel Therapeutics Inc is a biopharmaceutical company focused on the development of innovative therapeutics for the treatment of cancer

The company specializes in harnessing the power of oncolytic virus technology, which employs genetically modified viruses to selectively target and destroy tumor cells while also stimulating an immune response against cancer. Through its research and development initiatives, Candel aims to provide novel treatment options that enhance patient outcomes and address unmet medical needs in oncology.